perimenostage

Last checked November 2026 against 13 sources · Editorial policy

Vivelle-Dot: doses, price and whether it's still available

Vivelle-Dot is the original twice-weekly estradiol patch, sold by Sandoz and made by Noven. It comes in five doses, from 0.025 to 0.1 mg a day, on patches of 2.5 to 10.0 cm². It's still sold in November 2026, at around $158 for 8 low-dose patches for cash payers, and the FDA has approved generics from Mylan, Amneal and Zydus.

Vivelle-Dot twice-weekly estradiol patch: five doses, sizes, cash price, generics like Dotti, the 2026 patch shortage and FDA reports, checked November 2026.

Vivelle-Dot: expectation vs reality

What people often expect

“If your pharmacy can't find Vivelle-Dot, it's been discontinued and you'll have to change treatment”

What the evidence shows

Vivelle-Dot hasn't been withdrawn. In September 2026 the FDA said demand for estradiol patches had grown faster than supply, that it was working with all six manufacturers, and that patches remain available though brands vary by pharmacy. Approved generics of the same doses, including Dotti, can often fill the gap.

Vivelle-Dot: what you need to know

What Vivelle-Dot is

Vivelle-Dot is a thin estradiol patch you wear on your lower abdomen or buttocks and change twice a week. Estradiol is the same estrogen the ovaries make. The label lists hot flashes and night sweats, vaginal dryness and atrophy, low estrogen after the ovaries are removed or fail, and prevention of bone loss after menopause. Sandoz sells it, and the label names Noven Pharmaceuticals as the maker.

Learn more →

Vivelle-Dot doses and patch sizes

You can get five doses: 0.025, 0.0375, 0.05, 0.075 and 0.1 mg of estradiol a day. The patch is 2.5 cm² at the lowest dose and 10.0 cm² at the highest. For hot flashes the label starts at 0.0375 mg a day and adjusts by response; 0.025 mg is the dose for preventing bone loss. Generics like Dotti deliver the same doses on smaller patches.

Learn more →

How well Vivelle-Dot works for hot flashes

In two 12-week trials with Vivelle, the same estradiol system, 356 women took part, and the 0.075 and 0.1 mg doses beat placebo at weeks 4, 8 and 12. A third trial in 255 women, who started with 11.5 hot flashes a day on average, showed the 0.0375 mg dose also beat placebo for how often and how badly flashes came.

Learn more →

Is Vivelle-Dot still available?

Yes. Drugs.com listed cash prices for Vivelle-Dot in November 2026, and the FDA's September 2026 update says estradiol patches remain available while supply catches up with higher demand. What changes is which brand a given pharmacy has in stock. If yours is out, ask the pharmacist to check other stores or to substitute an approved generic of the same dose with your prescriber's agreement.

Learn more →

Vivelle-Dot generics

Drugs.com lists FDA-approved generics of Vivelle-Dot from Mylan Technologies (December 19, 2014), Amneal (February 4, 2019) and Zydus (December 1, 2022). Cost Plus Drugs sells Dotti, made by Amneal, as the generic for Vivelle-Dot. Approval doesn't guarantee a generic is on pharmacy shelves, so the brand and its generics can come and go by store.

Learn more →

Vivelle-Dot price

Drugs.com lists 8 Vivelle-Dot patches of 0.025 mg from $158.08 for cash payers in November 2026. The same box of Dotti starts at $58.60 and Minivelle at $102.52. That's a lot to pay for the name. If you're insured, check your plan's formulary before you fill it: the generic may sit on a lower tier.

Learn more →

Keeping Vivelle-Dot stuck

In 3 short trials with 471 observations, 85% of Vivelle-Dot patches stayed completely stuck for the whole wear time and 3% came off and were reapplied or replaced. If a patch falls off, the label says to reapply it or put a new one on another spot and keep your change days. Store patches in their pouches at room temperature.

Vivelle-Dot by the numbers

From the studies on this page

  • of patches stayed completely stuck in the label's adhesion data

    85%

356

women took part in the two trials where the 0.075 and 0.1 mg doses beat placebo

$158.08

is the cash price of 8 low-dose patches on Drugs.com, vs $58.60 for Dotti

3

companies have FDA-approved generics: Mylan, Amneal and Zydus

Prices are cash prices for the lowest dose in November 2026 and vary by pharmacy.

What people report to the FDA about Vivelle-Dot

Vivelle-Dot (estradiol transdermal system): 3,593 reports to the FDA, 1,383 serious · data through July 30, 2026

ReactionReportsShare
Didn't work535
14.9%
Hot flashes359
10.0%
Patch didn't stick338
9.4%
Headache265
7.4%
Fatigue210
5.8%
Nausea203
5.6%
  • Reports with any problem with the patch itself, such as sticking or how it was applied: 532 of 3,593 (14.8%). Doctors sent 921 reports (25.6%), a bigger share than for Minivelle, where patients sent 85.2%.

Vivelle-Dot or another patch: who each one suits

  • Vivelle-Dot if it's what your plan covers best

    Strong evidence

    The original twice-weekly patch with the most trial data behind its doses. If your insurance covers the brand at a low copay, or your pharmacy reliably stocks it, there's no reason to switch. Keep the same dose if you move to a generic later.

    Related guide →
  • Dotti if you pay cash

    Strong evidence

    The same five doses and twice-weekly schedule on a smaller patch, sold as the generic for Vivelle-Dot. On Drugs.com, 8 low-dose patches start at $58.60, against $158.08 for Vivelle-Dot, and the label reports the same adhesion figures.

    Related guide →
  • Minivelle if Vivelle-Dot keeps lifting

    Strong evidence

    Minivelle is made by Noven, delivers the same doses on the smallest US patch, and reports about 98% of observations with an adhesion score of 0, meaning at least 90% of the patch stayed stuck. It costs less than Vivelle-Dot for cash payers.

    Related guide →
  • A once-weekly patch if twice a week is hard to remember

    Some evidence

    Climara and its generics stay on for 7 days. The patches are larger and the doses run 0.025 to 0.1 mg a day in six steps, so your prescriber may need to pick the nearest match to your Vivelle-Dot dose.

    Related guide →

When to call a doctor on Vivelle-Dot

  • Urgent: Chest pain, sudden shortness of breath, a painful swollen leg, sudden vision loss or stroke signs

    Call 911. These can be signs of a blood clot or stroke, risks listed in the boxed warning of every estrogen patch.

  • Vaginal bleeding after menopause

    See your doctor soon. Unexpected bleeding on estrogen needs checking to rule out a problem with the uterine lining.

  • Hot flashes coming back after a switch to a generic or another brand

    Tell your prescriber. Check the dose on the new box first: doses match across twice-weekly brands, but a weekly patch has different steps.

    More →
  • A rash that spreads, blisters or won't settle when you move the patch

    Ask about another brand or switching to gel or pills.

    More →

Vivelle-Dot: questions women ask

Is Vivelle-Dot discontinued?

No. Drugs.com listed it with cash prices in November 2026. Pharmacies have had trouble keeping estradiol patches in stock because demand rose, and the FDA said in September 2026 it was working with all six manufacturers to raise supply. Ask your pharmacy to check other stores or an approved generic.

Related →

What is the generic for Vivelle-Dot?

On your pharmacy label it'll say estradiol transdermal system, twice weekly. Drugs.com lists approved generics from Mylan, Amneal and Zydus, and Cost Plus Drugs sells Dotti as the generic for Vivelle-Dot. They deliver the same doses, though patch size and adhesive differ.

Related →

How much does Vivelle-Dot cost?

Around $158.08 for 8 patches of 0.025 mg for cash payers on Drugs.com in November 2026; higher doses cost more. Dotti starts at $58.60 for the same box. With insurance, you pay your plan's copay, which is often lower for a generic.

Related →

What is the difference between Vivelle-Dot and Minivelle?

You'd get the same doses and schedule, and both are made by Noven. Minivelle is smaller, 1.65 to 6.6 cm² against 2.5 to 10.0 cm², and its label reports adhesion with a different scoring method. Minivelle had no separate efficacy trials: it was shown to be bioequivalent to Vivelle.

Related →

Where do you put a Vivelle-Dot patch?

Put it on clean, dry skin of your lower abdomen or buttocks, never on your breasts. Change it twice a week on the same two days and use a different spot each time. Avoid the waistband, where clothes rub the patch loose.

Related →

What is the starting dose of Vivelle-Dot?

For hot flashes you'd usually start at 0.0375 mg a day, changed twice weekly, and your prescriber adjusts from there. For preventing bone loss the dose is 0.025 mg a day. Use the lowest dose that works for as long as you need it.

Related →

Do I need progesterone with Vivelle-Dot?

If you still have a uterus, yes. Estrogen alone raises the risk of endometrial cancer, so a progestogen such as micronized progesterone or a hormonal IUD is added. After a hysterectomy, estrogen alone is usually enough.

Related →

Sources

  1. Prescribing information: Vivelle-Dot (estradiol transdermal system). Sandoz, 2023. DailyMed, US National Library of Medicine.
  2. Drugs.com. Vivelle-Dot prices, coupons, copay cards and patient assistance. Accessed November 2, 2026.
  3. Drugs.com. Generic Vivelle-Dot availability: FDA-approved generics, manufacturers and approval dates. Accessed November 2, 2026.
  4. US Food and Drug Administration. FDA update on estradiol transdermal patch availability. September 3, 2026.
  5. Mark Cuban Cost Plus Drug Company. Hormone therapy medication prices (checked September 2026).
  6. Prescribing information: Dotti (estradiol transdermal system), 2024. DailyMed, US National Library of Medicine.
  7. Drugs.com. Dotti prices, coupons, copay cards and patient assistance. Accessed November 2, 2026.
  8. Drugs.com. Minivelle prices, coupons, copay cards and patient assistance. Accessed November 2, 2026.
  9. Prescribing information: Minivelle (estradiol transdermal system). Noven Therapeutics, 2026. DailyMed, US National Library of Medicine.
  10. Prescribing information: Climara (estradiol transdermal system). Bayer HealthCare, 2026. DailyMed, US National Library of Medicine.
  11. National 911 Program. 911.gov.
  12. US Food and Drug Administration. FDA Adverse Event Reporting System (FAERS): reports naming Vivelle-Dot (estradiol transdermal system, twice weekly), via openFDA. Data through July 30, 2026.
  13. US Food and Drug Administration. FDA Adverse Event Reporting System (FAERS): reports naming Minivelle (estradiol transdermal system, twice weekly), via openFDA. Data through July 30, 2026.

See our editorial policy.

Related guides

Doctor-ready summary

Your stage in 2 minutes.

You leave with a stage estimate and a one-page summary sized for a short appointment.

Begin 2-minute stage check

Private · No app download

Sample report

Stage estimateLate transition
Sleep driving burden · TSH worth ruling out